Logo image of TYDE

CRYPTYDE INC (TYDE) Stock Fundamental Analysis

NASDAQ:TYDE - Nasdaq - US22890A1043 - Common Stock - Currency: USD

0.0571  -0.03 (-31.37%)

After market: 0.06 +0 (+5.08%)

Fundamental Rating

1

Taking everything into account, TYDE scores 1 out of 10 in our fundamental rating. TYDE was compared to 24 industry peers in the Containers & Packaging industry. TYDE may be in some trouble as it scores bad on both profitability and health. TYDE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TYDE has reported negative net income.
TYDE Yearly Net Income VS EBIT VS OCF VS FCFTYDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 -200K -400K -600K

1.2 Ratios

TYDE has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TYDE Yearly ROA, ROE, ROICTYDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 0 20 40 60 80

1.3 Margins

TYDE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TYDE Yearly Profit, Operating, Gross MarginsTYDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021

More info and screens

3

2. Health

2.1 Basic Checks

TYDE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TYDE Yearly Shares OutstandingTYDE Yearly Shares OutstandingYearly Shares Outstanding 2021 2M 4M 6M 8M 10M
TYDE Yearly Total Debt VS Total AssetsTYDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -2.35, we must say that TYDE is in the distress zone and has some risk of bankruptcy.
TYDE has a worse Altman-Z score (-2.35) than 87.50% of its industry peers.
TYDE has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
TYDE has a Debt to Equity ratio of 1.22. This is in the better half of the industry: TYDE outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Altman-Z -2.35
ROIC/WACCN/A
WACCN/A
TYDE Yearly LT Debt VS Equity VS FCFTYDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 -100K -200K -300K -400K -500K

2.3 Liquidity

TYDE has a Current Ratio of 1.95. This is a normal value and indicates that TYDE is financially healthy and should not expect problems in meeting its short term obligations.
TYDE has a Current ratio of 1.95. This is in the better half of the industry: TYDE outperforms 79.17% of its industry peers.
A Quick Ratio of 1.95 indicates that TYDE should not have too much problems paying its short term obligations.
TYDE has a better Quick ratio (1.95) than 95.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.95
TYDE Yearly Current Assets VS Current LiabilitesTYDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TYDE Yearly Revenue VS EstimatesTYDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021
TYDE Yearly EPS VS EstimatesTYDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TYDE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TYDE Price Earnings VS Forward Price EarningsTYDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TYDE Per share dataTYDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

1

5. Dividend

5.1 Amount

TYDE has a Yearly Dividend Yield of 1.26%.
The stock price of TYDE dropped by -82.40% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.15, TYDE is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.27, TYDE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

TYDE does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
TYDE Yearly Income VS Free CF VS DividendTYDE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 -100K -200K -300K -400K -500K

More info and screens

CRYPTYDE INC

NASDAQ:TYDE (4/3/2023, 8:01:58 PM)

After market: 0.06 +0 (+5.08%)

0.0571

-0.03 (-31.37%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)11-29 2022-11-29/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.81M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-1.46
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.5
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.95
Altman-Z -2.35
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A